mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.3 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.3 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |